Skip to main content
Premium Trial:

Request an Annual Quote

GenMark Gets FDA OK for Respiratory Virus Panel

NEW YORK (GenomeWeb News) – GenMark Diagnostics has received US Food and Drug Administration 510(k) clearance for its eSensor Respiratory Virus Panel.

The test simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illness. According to GenMark, it has the "potential to significantly improve patient care by delivering superior co-infection detection, distinguishing rhinovirus from enteroviruses and identifying clinically relevant adenoviruses."

The test runs on the firm's eSensor XT-8 system.

The RVP test is the fourth FDA-cleared molecular diagnostic for GenMark, joining the firm's cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test. The Carlsbad, Calif.-based firm also is developing a hepatitis C virus test and a 2C19 test.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.